Aardvark Therapeutics, Inc. (AARD) stock
AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.11 (-8.73%)
Close on Nov 17, 2026Market cap $25.17MP/E –Yield –
Aardvark Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Aardvark Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 1.8× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −1.9 |
| 2025 | Dec 31, 2025 | 2.3× | – |
See a number that looks wrong?